pembrolizumab,vibostolimab,favezelimab
merck
['#gu,(-#gui),(-#gunagratinib),(-#guard),(-#gut)', 'kn057']
the #oncoalerttoptweet day 2 #gu23
tweet on kn057 trial! meaningful data on efficacy &amp; safety
very important need in pts who decline/cant have radical cystectomy 
🌐 Worldwide Network of Oncology Professionals & Patient Advocates with the common goal of ending cancer, we are Oncology360 degrees 🌎 We are #OncoAlert 🚨